Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ketty, Hu"'
Autor:
Ketty Hu-Heimgartner, Noémie Lang, Aurélie Ayme, Chang Ming, Jean‑Damien Combes, Victor N. Chappuis, Carla Vazquez, Alex Friedlaender, Aurélie Vuilleumier, Alexandre Bodmer, Valeria Viassolo, José L Sandoval, Pierre O. Chappuis, S. Intidhar Labidi-Galy
Publikováno v:
Familial Cancer.
BRCA1 and BRCA2 play a central role in DNA repair and their germline pathogenic variants (gBRCA) confer a high risk for developing breast and ovarian cancer. Standard chemotherapy regimens for these cancers include DNA-damaging agents. We hypothesize
Publikováno v:
Revue medicale suisse. 18(797)
We report on the case of a 73-year-old man, who was referred to our emergency department for confusion and dyspnea. He had been under a treatment of flucloxacillin for six weeks because of a possible methicillin-susceptible Staphylococcus aureus (MSS
Publikováno v:
Revue Médicale Suisse. 18:1825-1827
Autor:
S. Intidhar Labidi-Galy, Killian Heimgartner, Jean-Christophe Tille, Prasad Chaskar, Lou Romanens, Ketty Hu-Heimgartner, Gürkan Kaya, Petros Tsantoulis, Nicolas Liaudet, Stephan Ryser
Tumor samples are conserved in clinical practice in formalin-fixed paraffin-embedded (FFPE) blocks. Formalin fixation chemically alters nucleic acids, rendering transcriptomic analysis challenging. RNA-sequencing is usually performed on tumor bulk, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4843d979c4a4a54d709acf9a84ed8d7
https://doi.org/10.1101/2020.01.31.928143
https://doi.org/10.1101/2020.01.31.928143
Autor:
Adrien Buisson, Fernando Bazan, Timothée Olivier, Olivier Tredan, Valérie Bonadona, Elsa Kalbacher, Hemerson Guevara, Anita Wolfer, Ketty Hu, Jean-Damien Combes, Lisa Golmard, Victoire de Castelbajac, Thibault De La Motte Rouge, Sana Intidhar Labidi-Galy, Olfa Derbel, Valeria Viassolo, Manuel Rodrigues, Isabelle Ray-Coquard, Pauline Vaflard, Louise Crivelli
Publikováno v:
Journal of Clinical Oncology. 36:5558-5558
5558Background: To investigate clinical factors predictive for prolonged progression-free survival (PFS) in ovarian cancer (OC) patients carrying BRCA mutations and receiving olaparib as a maintena...